Respiratory Innovation Summit Positions Leaders to Transform Ideas into Impact

The 2025 Respiratory Innovation Summit, hosted alongside the ATS 2025 International Conference in San Francisco, will unite innovators, investors, clinicians, and advocacy groups leading efforts to develop new treatments for diseases affecting patients’ lungs and airways. The RIS historically has featured more than 390 global attendees, including leaders from start-ups, business development, venture capital, government, academia, and clinical medicine.